Hereditary motor and sensory neuropathy – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:31:15 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Hereditary motor and sensory neuropathy – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Safety and Effectiveness of NMD670 for Adults with Charcot-Marie-Tooth Disease Types 1 and 2 https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-nmd670-for-adults-with-charcot-marie-tooth-disease-types-1-and-2/ Wed, 29 Apr 2026 14:27:27 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-nmd670-for-adults-with-charcot-marie-tooth-disease-types-1-and-2/ This clinical trial is focused on studying Charcot-Marie-Tooth Disease (CMT), specifically types 1 and 2. CMT is a group of inherited disorders that affect the peripheral nerves, which are responsible for movement and sensation in the limbs. The trial will evaluate a new treatment called NMD670, which is taken as a tablet. The purpose of the study is to assess how effective and safe NMD670 is for patients with CMT.

Participants in the study will be randomly assigned to receive either the NMD670 tablet or a placebo, which looks like the NMD670 tablet but does not contain the active ingredient. The study will last for 21 days, during which participants will take the tablets daily. Throughout the study, participants will undergo various assessments to monitor their progress and any changes in their condition.

The main focus of the study is to observe changes in the distance participants can walk over a set period, as well as the time it takes to complete certain walking tasks. These assessments will help determine the effectiveness of NMD670 in improving mobility and overall function in individuals with Charcot-Marie-Tooth Disease. The study aims to provide valuable insights into the potential benefits of NMD670 for people living with this condition.

]]> CMTP https://clinicaltrials.eu/organisation/cmtp/ Wed, 29 Apr 2026 13:34:18 +0000 https://clinicaltrials.eu/organisation/cmtp/ Charcot-Marie-Tooth Polska (CMTP.pl) is a volunteer initiative born from the heartfelt need of parents of a child with CMT. Its primary goal is to fill the information gap surrounding Charcot-Marie-Tooth disease, which, despite being the most common inherited neurological disorder, often remains undiagnosed or misdiagnosed. The website is a treasure trove of reliable information – from basic data on CMT and its symptoms, through disease types and diagnostics, to practical aspects of living with it.

]]>